ArticleExploration (Beijing, China)2026
A PD-L1 Nanobody-Engineered Synthetic RNA Virus Enhances Hepatocellular Carcinoma Immunotherapy by Interfering PCSK9 and Upregulating MHC-I.
Chuyu Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.